Bekaii-Saab, Tanios <br/><br/>
A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomas.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Sep 2009 
 - 5895-901 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-09-0465  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Hepatocellular--drug therapy<br/>Disease Progression<br/>Dose-Response Relationship, Drug<br/>Drug-Related Side Effects and Adverse Reactions<br/>Female<br/>Humans<br/>Lapatinib<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Predictive Value of Tests<br/>Quinazolines--administration & dosage<br/>Survival Rate